Antrodia cinnamomea supplement for people with lung cancer having chemotherapy
Tests Antrodia cinnamomea capsules on quality of life in lung cancer patients on chemotherapy.
Key facts
- Who runs it
- Tri-Service General Hospital (TSGH)
- Where
- Taipei, TaiwanSee the site
- Trial code
- Registry title
- Antrodia Cinnamomea Extract Effects on Lung Cancer Patients' Quality of Life During Chemotherapy
- Status
- Recruiting
- People taking part
- 40 people, planned
- Started
- 24 Nov 2025
- Expected to end
- 30 Sept 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Antrodia cinnamomea supplement
- Turmeric-Probiotic Group
- Record updated
- 8 January 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with lung cancer who have received platinum-based chemotherapy and are expected to live six months or longer.
- Age
- Older than 18 years, up to 99 years
- Sex
- All sexes can join
- Disease stage
- Lung cancer confirmed by tissue examination and imaging
- Earlier treatment
- Must have received platinum-based chemotherapy
Main reasons for not taking part
- Abnormal liver or kidney function in the 14 days before entry
- Unexplained fever of 38.5°C (101.3 °F) or higher for 7 days in a row, or diarrhea for 15 days in a row, in the last 30 days
- Currently on hormone therapy
- Major heart disease, severe arrhythmia or major nerve damage
- Active acute infection, or allergy to the study product
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Pathologically and radio-graphically diagnosed lung cancer
- Age greater than 18 years
- Received platinum-based chemotherapy
- Life expectancy of six months or longer
Who cannot take part
- Within 30 days prior to trial entry, unexplained fever ≥38.5°C for 7 consecutive days or chronic diarrhea for 15 consecutive days
- Currently receiving hormone therapy
- Patients with known allergies/allergic reactions to the investigational product or any components in their formulations
- Patients currently taking supplements containing Antrodia camphorata extract
- Major cardiac disease or arrhythmia severe enough that the attending physician considers the patient unsuitable for trial participation
- Patients with currently active acute infections
- Within 14 days prior to trial entry, laboratory data showing abnormal liver function, abnormal kidney function
- Inability to comply with timely supplementation administration
- Major neuropathy
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 99 years old?
Where in Taiwan
- Tri-Service General HospitalTaipei, TaiwanContact: Chen-Liang TsaiTaking people
About the trial
What the trial wants to find out
This randomized trial will test whether Antrodia cinnamomea supplement improves quality of life in lung cancer patients receiving platinum-based chemotherapy.
Read full original descriptionShow less
Participants at Tri-Service General Hospital will be randomized to receive either Antrodia cinnamomea capsules or placebo for 3 months, with follow-up to 6 months (24 weeks). Primary outcomes include nausea/vomiting scores, sleep quality, quality of life, and cancer symptoms.
The 2 groups in the trial
- Antrodia cinnamomea plus turmeric and probioticsTreatment being tested
Participants will receive capsules containing Antrodia cinnamomea extract, turmeric, and probiotics taken orally once daily for 3 months during platinum-based chemotherapy treatment.
Treatment: Antrodia cinnamomea supplement
- Turmeric and probiotics onlyExisting treatment, for comparison
Participants will receive capsules containing turmeric and probiotics (without Antrodia cinnamomea) taken orally once daily for 3 months during platinum-based chemotherapy treatment.
Treatment: Turmeric-Probiotic Group
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- The Effects of Antrodia Cinnamomea Fruiting Body Extract on Quality of Life and Chemotherapy Side Effects in Patients With Lung Cancer Undergoing Platinum-Based Chemotherapy
- Plain-language title
- Antrodia cinnamomea supplement for people with lung cancer having chemotherapyGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT07241182, who can take part
- Record updated
- 8 January 2026